The North America Tolvaptan Market reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. North America Tolvaptan Market By Applications Applications:– Hyponatremia– Autosomal Dominant Polycystic Kidney Disease (ADPKD)– Syndrome of Inappropriate Antidiuretic Hormone (SIADH)– […]